255 related articles for article (PubMed ID: 29326178)
1. Impact of replacing cytology with human papillomavirus testing for cervical cancer screening on the prevalence of
Hui BB; Reulein CP; Guy RJ; Donovan B; Hocking JS; Law MG; Regan DG
Sex Transm Infect; 2018 May; 94(3):216-221. PubMed ID: 29326178
[TBL] [Abstract][Full Text] [Related]
2. Supplemental
Regan DG; Hui BB; Guy RJ; Donovan B; Hocking JS; Law MG
Sex Transm Infect; 2020 Feb; 96(1):76-78. PubMed ID: 30992326
[TBL] [Abstract][Full Text] [Related]
3. An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening.
Lazenby GB; Taylor PT; Badman BS; McHaki E; Korte JE; Soper DE; Young Pierce J
Clin Ther; 2014 Jan; 36(1):38-45. PubMed ID: 24417784
[TBL] [Abstract][Full Text] [Related]
4. Co-infection with trichomonas vaginalis increases the risk of cervical intraepithelial neoplasia grade 2-3 among HPV16 positive female: a large population-based study.
Yang M; Li L; Jiang C; Qin X; Zhou M; Mao X; Xing H
BMC Infect Dis; 2020 Sep; 20(1):642. PubMed ID: 32873233
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of Trichomonas vaginalis and human papillomavirus infection detected by real-time PCR in flanders.
Depuydt CE; Leuridan E; Van Damme P; Bogers J; Vereecken AJ; Donders GG
Gynecol Obstet Invest; 2010; 70(4):273-80. PubMed ID: 21051847
[TBL] [Abstract][Full Text] [Related]
6. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
[TBL] [Abstract][Full Text] [Related]
7. How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country.
Velentzis LS; Caruana M; Simms KT; Lew JB; Shi JF; Saville M; Smith MA; Lord SJ; Tan J; Bateson D; Quinn M; Canfell K
Int J Cancer; 2017 Dec; 141(12):2410-2422. PubMed ID: 28801947
[TBL] [Abstract][Full Text] [Related]
8. Association of Trichomonas vaginalis and cytological abnormalities of the cervix in low risk women.
Donders GG; Depuydt CE; Bogers JP; Vereecken AJ
PLoS One; 2013; 8(12):e86266. PubMed ID: 24386492
[TBL] [Abstract][Full Text] [Related]
9. Projected Impact of HPV and LBC Primary Testing on Rates of Referral for Colposcopy in a Canadian Cervical Cancer Screening Program.
Coldman AJ; Phillips N; van Niekerk D; Smith L; Krajden M; Cook D; Quinlan DJ; Ehlen T; Miller D; Stuart GC; Peacock S; Martin RE; Franco EL; Ogilvie G
J Obstet Gynaecol Can; 2015 May; 37(5):412-420. PubMed ID: 26168101
[TBL] [Abstract][Full Text] [Related]
10. Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use.
Smith MA; Gertig D; Hall M; Simms K; Lew JB; Malloy M; Saville M; Canfell K
BMC Health Serv Res; 2016 Apr; 16():147. PubMed ID: 27112193
[TBL] [Abstract][Full Text] [Related]
11. Trichomonas vaginalis: underdiagnosis in urban Australia could facilitate re-emergence.
Lusk MJ; Naing Z; Rayner B; Rismanto N; McIver CJ; Cumming RG; McGeechan K; Rawlinson WD; Konecny P
Sex Transm Infect; 2010 Jun; 86(3):227-30. PubMed ID: 19880969
[TBL] [Abstract][Full Text] [Related]
12. Atypical Squamous Cells in Liquid-Based Cervical Cytology: Microbiology, Inflammatory Infiltrate, and Human Papillomavirus-DNA Testing.
Gomes de Oliveira G; Eleutério RMN; Silveira Gonçalves AK; Giraldo PC; Eleutério J
Acta Cytol; 2018; 62(1):28-33. PubMed ID: 29130974
[TBL] [Abstract][Full Text] [Related]
13. Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multipathogen screening in women, including female genital schistosomiasis, human papillomavirus, Trichomonas and HIV in Zambia.
Shanaube K; Ndubani R; Kelly H; Webb E; Mayaud P; Lamberti O; Fitzpatrick J; Kasese N; Sturt A; Van Lieshout L; Van Dam G; Corstjens PLAM; Kosloff B; Bond V; Hayes R; Terris-Prestholt F; Webster B; Vwalika B; Hansingo I; Ayles H; Bustinduy AL
BMJ Open; 2024 Jun; 14(6):e080395. PubMed ID: 38858160
[TBL] [Abstract][Full Text] [Related]
14. Primary HPV testing: a proposal for co-testing in initial rounds of screening to optimise sensitivity of cervical cancer screening.
Herbert A
Cytopathology; 2017 Feb; 28(1):9-15. PubMed ID: 27005867
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of human papillomavirus, Chlamydia trachomatis, and Trichomonas vaginalis infections in Amazonian women with normal and abnormal cytology.
Costa-Lira E; Jacinto AHVL; Silva LM; Napoleão PFR; Barbosa-Filho RAA; Cruz GJS; Astolfi-Filho S; Borborema-Santos CM
Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28453175
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Risk Factors of Trichomonas vaginalis Among Female Sexual Workers in Nairobi, Kenya.
Lockhart A; Senkomago V; Ting J; Chitwa M; Kimani J; Gakure H; Kwatampora J; Patel S; Mugo N; Smith JS
Sex Transm Dis; 2019 Jul; 46(7):458-464. PubMed ID: 31194717
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus testing in young women: clinical outcomes of human papillomavirus triage in a UK cervical screening program.
McKenna M; McMenamin MM
Cancer Cytopathol; 2014 Sep; 122(9):702-10. PubMed ID: 24888573
[TBL] [Abstract][Full Text] [Related]
18. Risk assessment to guide cervical screening strategies in a large Chinese population.
Zhao FH; Hu SY; Zhang Q; Zhang X; Pan QJ; Zhang WH; Gage JC; Wentzensen N; Castle PE; Qiao YL; Katki HA; Schiffman M
Int J Cancer; 2016 Jun; 138(11):2639-47. PubMed ID: 26800481
[TBL] [Abstract][Full Text] [Related]
19. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.
Kim JJ; Burger EA; Sy S; Campos NG
J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27754955
[TBL] [Abstract][Full Text] [Related]
20. Triage of women with negative cytology and positive high-risk HPV: an analysis of data from the SHENCCAST II/III studies.
Goodrich SK; Pretorius RG; Du H; Wu R; Belinson JL
J Low Genit Tract Dis; 2014 Apr; 18(2):122-7. PubMed ID: 24270196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
